Ceramide-Mediated Lipid Remodeling in Fish Nodavirus Infection

Study Background and Research Question

Viral nervous necrosis (VNN), caused by nervous necrosis virus (NNV), poses a major threat to aquaculture, especially affecting larval and juvenile marine fish. The red-spotted grouper nervous necrosis virus (RGNNV) is particularly notorious for its high mortality rates. Previous research has highlighted how RGNNV exploits host cell fatty acid synthesis and induces membrane remodeling to aid its life cycle. However, the precise roles of lipid metabolism—and specifically sphingolipid intermediates like ceramides—during RGNNV infection have remained unclear (paper).

Key Innovation from the Reference Study

This study represents the first comprehensive lipidomic profiling of RGNNV-infected fish cells, revealing that ceramides are not only upregulated but also act as pro-viral mediators. The work demonstrates that RGNNV actively manipulates all major ceramide synthesis pathways to enhance its own replication, with ceramide accumulation supporting autophagy, a process critical for viral propagation (paper).

Methods and Experimental Design Insights

The authors utilized global lipidomics to compare the lipid profiles of RGNNV-infected and uninfected grouper cells. They quantified changes in ceramide species through mass spectrometry and assessed gene expression levels of key ceramide synthesis enzymes by qPCR. Protein localization studies used immunofluorescence to visualize colocalization of ceramides with viral capsid protein (CP) and RNA-dependent RNA polymerase (RdRp). Functional assays included pharmacological inhibition and gene knockdown of ceramide synthesis, as well as rescue experiments with exogenous C16-ceramide (d18:1/16:0). Autophagy was probed by modulating its pathway and assessing effects on viral replication.

Core Findings and Why They Matter

1. Ceramide Accumulation Is a Hallmark of RGNNV Infection: Lipidomic analysis revealed that nearly all detectable ceramide species were significantly elevated in RGNNV-infected cells. This was accompanied by upregulation of mRNA for ceramide synthesis enzymes, suggesting a coordinated metabolic shift (paper).

2. Viral Capsid Protein Drives Ceramide Synthesis: Immunofluorescence showed that virus-induced ceramides colocalize specifically with the RGNNV capsid protein (CP), not with RdRp. Ectopic expression of CP alone recapitulated ceramide upregulation, indicating that the virus manipulates host lipid metabolism through this structural protein.

3. All Ceramide Synthesis Pathways Are Required for Infection: Disruption of de novo, salvage, and sphingomyelinase-dependent ceramide synthesis—either pharmacologically or by knockdown—markedly suppressed RGNNV replication. This suppression was reversed by supplementing with exogenous C16-ceramide, confirming ceramides’ essential pro-viral role.

4. Ceramides Promote Viral Replication via Autophagy: C16-ceramide enhanced RGNNV-induced autophagy and counteracted the antiviral effect of chloroquine, an autophagy inhibitor. These results suggest that ceramides facilitate viral propagation by promoting autophagic processes, highlighting a critical mechanism in host-pathogen interaction (paper).

Protocol Parameters

• lipidomic profiling | LC-MS/MS, untargeted | detection of sphingolipid changes | enables comprehensive mapping of lipid alterations during infection | paper
• ceramide quantification | pmol/mg protein (typical range: 10–500) | RGNNV-infected vs. control cells | quantifies ceramide accumulation | paper
• autophagy assessment | LC3-II expression, immunoblot | RGNNV-infected cells | monitors autophagic flux in response to viral infection and intervention | paper
• pharmacological inhibition | myriocin (0.5–2 μM), fumonisin B1 (5–20 μM) | inhibition of ceramide synthesis | establishes causal role for ceramides in viral replication | paper
• exogenous ceramide rescue | C16-ceramide (1–10 μM) | rescue assay after pathway inhibition | confirms specificity of ceramide requirement | paper
• apoptosis/autophagy cross-application | Imipramine (10–50 μM) | glioma cell autophagy or HL-60 apoptosis | workflow extrapolation for tricyclic antidepressant studies | workflow_recommendation

Comparison with Existing Internal Articles

Several internal resources have explored the intersection of lipid metabolism, autophagy, and the pharmacology of tricyclic antidepressants. For example, "Imipramine: Tricyclic Antidepressant as a Translational Oncology Tool" discusses how Imipramine, beyond its classical antidepressant function, modulates autophagy in glioma cells and triggers apoptosis in HL-60 leukemia cells. These findings are conceptually aligned with the reference study, in that both implicate lipid homeostasis and autophagy as central mechanisms in disease contexts—whether viral or oncological. Similarly, "Imipramine in Glioma and HL-60 Research: Workflows & Troubleshooting" provides practical guidance for leveraging Imipramine in autophagy and apoptosis assays, echoing the workflow logic seen in the reference paper’s use of ceramide pathway modulation. The shared mechanistic theme of lipid remodeling and autophagy supports cross-talk between antiviral, cancer, and neuroscience research domains (workflow_recommendation).

Limitations and Transferability

While this study establishes a clear pro-viral role for ceramides during RGNNV infection in vitro, several limitations constrain the direct transferability of these findings. First, the experiments are limited to grouper cell models, and the in vivo relevance in whole organisms or other fish species remains to be established. Second, the detailed molecular interactions between ceramides, viral proteins, and host autophagic machinery require further elucidation. Finally, while ceramide-mediated autophagy is shown to assist viral replication, the balance between pro-survival and pro-death autophagic pathways is context-dependent and may be influenced by additional host or viral factors (paper).

Why this cross-domain matters, maturity, and limitations

The manipulation of host lipid metabolism by pathogens mirrors similar strategies employed in cancer biology and neuroscience, where autophagy modulation is a therapeutic target. Insights from this RGNNV–ceramide study can inform the design of antiviral, anticancer, and neuroprotective workflows, particularly where tricyclic antidepressants like Imipramine are used to modulate autophagy or apoptosis. However, cross-domain application requires careful validation, as the mechanistic details and cellular context may differ significantly between viral infection and oncogenic or neurodegenerative processes (workflow_recommendation).

Research Support Resources

Researchers aiming to investigate autophagy, apoptosis, or lipid remodeling in viral, cancer, or neuroscience contexts can employ agents such as Imipramine (SKU BA2970), a tricyclic antidepressant with documented roles in glioma autophagy and HL-60 apoptosis research (source: product_spec). Imipramine is supplied for research use only and may support workflows that parallel those described in ceramide-mediated autophagy studies, but protocol optimization and context-specific controls are recommended.

---

• Zhang Y, Liu L, Lin L, et al. Lipidomics reveals the pro-viral roles of ceramides during fish nodavirus infection. J Virol. 2026;100(3):e01991-25. (open-access)